Yifeng Pharmacy Chain Statistics
Total Valuation
SHA:603939 has a market cap or net worth of CNY 32.04 billion. The enterprise value is 29.27 billion.
Market Cap | 32.04B |
Enterprise Value | 29.27B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
Earnings Date | Aug 29, 2025 |
Ex-Dividend Date | Oct 15, 2024 |
Share Statistics
SHA:603939 has 1.21 billion shares outstanding. The number of shares has increased by 1.53% in one year.
Current Share Class | 1.21B |
Shares Outstanding | 1.21B |
Shares Change (YoY) | +1.53% |
Shares Change (QoQ) | -4.67% |
Owned by Insiders (%) | 11.85% |
Owned by Institutions (%) | 21.66% |
Float | 555.37M |
Valuation Ratios
The trailing PE ratio is 20.80 and the forward PE ratio is 17.91. SHA:603939's PEG ratio is 2.59.
PE Ratio | 20.80 |
Forward PE | 17.91 |
PS Ratio | 1.33 |
PB Ratio | 2.69 |
P/TBV Ratio | 5.39 |
P/FCF Ratio | 7.85 |
P/OCF Ratio | 6.84 |
PEG Ratio | 2.59 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.06, with an EV/FCF ratio of 7.17.
EV / Earnings | 18.63 |
EV / Sales | 1.21 |
EV / EBITDA | 7.06 |
EV / EBIT | 12.87 |
EV / FCF | 7.17 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.42.
Current Ratio | 1.31 |
Quick Ratio | 0.90 |
Debt / Equity | 0.42 |
Debt / EBITDA | 1.21 |
Debt / FCF | 1.23 |
Interest Coverage | 9.82 |
Financial Efficiency
Return on equity (ROE) is 14.81% and return on invested capital (ROIC) is 8.51%.
Return on Equity (ROE) | 14.81% |
Return on Assets (ROA) | 5.27% |
Return on Invested Capital (ROIC) | 8.51% |
Return on Capital Employed (ROCE) | 14.51% |
Revenue Per Employee | 602,236 |
Profits Per Employee | 39,265 |
Employee Count | 40,018 |
Asset Turnover | 0.89 |
Inventory Turnover | 3.57 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.87% in the last 52 weeks. The beta is 0.50, so SHA:603939's price volatility has been lower than the market average.
Beta (5Y) | 0.50 |
52-Week Price Change | -26.87% |
50-Day Moving Average | 27.12 |
200-Day Moving Average | 24.08 |
Relative Strength Index (RSI) | 47.66 |
Average Volume (20 Days) | 5,838,428 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603939 had revenue of CNY 24.10 billion and earned 1.57 billion in profits. Earnings per share was 1.27.
Revenue | 24.10B |
Gross Profit | 9.61B |
Operating Income | 2.28B |
Pretax Income | 2.24B |
Net Income | 1.57B |
EBITDA | 2.53B |
EBIT | 2.28B |
Earnings Per Share (EPS) | 1.27 |
Balance Sheet
The company has 8.50 billion in cash and 5.02 billion in debt, giving a net cash position of 3.48 billion or 2.87 per share.
Cash & Cash Equivalents | 8.50B |
Total Debt | 5.02B |
Net Cash | 3.48B |
Net Cash Per Share | 2.87 |
Equity (Book Value) | 11.89B |
Book Value Per Share | 9.23 |
Working Capital | 3.77B |
Cash Flow
In the last 12 months, operating cash flow was 4.69 billion and capital expenditures -602.90 million, giving a free cash flow of 4.08 billion.
Operating Cash Flow | 4.69B |
Capital Expenditures | -602.90M |
Free Cash Flow | 4.08B |
FCF Per Share | 3.37 |
Margins
Gross margin is 39.87%, with operating and profit margins of 9.44% and 6.52%.
Gross Margin | 39.87% |
Operating Margin | 9.44% |
Pretax Margin | 9.28% |
Profit Margin | 6.52% |
EBITDA Margin | 10.51% |
EBIT Margin | 9.44% |
FCF Margin | 16.94% |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 3.07%.
Dividend Per Share | 0.80 |
Dividend Yield | 3.07% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | 53.71% |
Buyback Yield | -1.53% |
Shareholder Yield | 1.54% |
Earnings Yield | 4.90% |
FCF Yield | 12.74% |
Stock Splits
The last stock split was on June 7, 2024. It was a forward split with a ratio of 1.2.
Last Split Date | Jun 7, 2024 |
Split Type | Forward |
Split Ratio | 1.2 |
Scores
SHA:603939 has an Altman Z-Score of 2.8. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.8 |
Piotroski F-Score | n/a |